{"schema_version":"secwatch.filing_event.v1","accession":"0001127537-23-000032","form_type":"8-K","ticker":"LUNG","cik":"0001127537","company_name":"Pulmonx Corp","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.202123+00:00","generated_at":"2026-06-12T11:34:35.121186+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pulmonx Q2 revenue $17.2M (+23% YoY), raises FY2023 guidance to $64-66M","bullets":["Record worldwide revenue $17.2M, up 23% YoY; US revenue $11.0M up 28% YoY.","Gross margin 74% (vs 75% prior year); net loss $16.2M ($0.43/share).","Raised 2023 revenue guidance to $64-66M (from $63-65M); operating expenses maintained at $112-114M.","Added 15 new US Zephyr Valve treatment centers in Q2."],"urls":{"canonical":"https://secwatch.observer/filing/0001127537-23-000032","json":"https://secwatch.observer/filing/0001127537-23-000032.json","markdown":"https://secwatch.observer/filing/0001127537-23-000032.md","text":"https://secwatch.observer/filing/0001127537-23-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1127537/000112753723000032/0001127537-23-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1127537/000112753723000032/lung-20230802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T11:34:35.121186+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5f75b5afa7296e6058b26b825de2873156c91d84","claim":"Pulmonx Corp reported second quarter of 2023 ended June 30, 2023 results: revenue $17.2 million, net income $16.2 million, EPS $0.43 per share. Guidance raised.","evidence_excerpt":"treatments for lung disease, today reported financial results for the second quarter of 2023 ended June 30, 2023. Recent Highlights • Achieved record worldwide revenue of $17.2 million in the second quarter of 2023, a 23% increase over the same period last year • Delivered a new high of $11.0 million in U.S. revenue in the second quarter of 2023, representing","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1127537/000112753723000032/0001127537-23-000032-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter of 2023 ended June 30, 2023"},{"label":"Revenue","value":"$17.2 million"},{"label":"Net income","value":"$16.2 million"},{"label":"EPS","value":"$0.43 per share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}